Member Exclusive

NICE approves Kymriah for use in adults following commercial agreement with NHS England

Kymriah was previously approved for patients under the age of 25 with B-cell acute lymphoblastic leukemia.

Go to the profile of Freya Leask
Feb 01, 2019

Please sign in or register for FREE

No comments yet.